Nephrogenic Systemic Fibrosis
AttorneyOne.com is a free nationwide legal referral service. We are not a law firm. We help consumers find the best representation for their legal needs.
If you or a loved one are in need of legal assistance concerning Nephrogenic Systemic Fibrosis you should get a lawyer on your side immediately. You will pay no attorney fees unless you win your case.
Email up to 10 Nephrogenic Systemic Fibrosis law firms in one click; by filling out the simple Free Case Evaluation form.
For additional info on Nephrogenic Systemic Fibrosis use the related topic links on the far right.
Nephrogenic Systemic Fibrosis
Nephrogenic systemic fibrosis (NSF) is a disease that has been tentatively identified as a side effect from the use of gadolinium based contrast dyes during MRI exams. As more information about the affliction has emerged, another name came into general use for the disease: Nephrogenic Fibrosing Dermopathy (NFD). In literature on the subject, you will often see nephrogenic systemic fibrosis referred to as NSF/NFD. By any name, the disease is a severe and potentially fatal health problem.
The principal symptoms of nephrogenic systemic fibrosis are hardening of the skin, stiffness in the joints and weakness of the limbs. The disease can become evident weeks or months after the MRI exam. Thus far, it has affected patients with kidney problems almost exclusively. After only weeks following the onset of the disorder, the skin surrounding the joints on limbs can become so thick and hardened and movement so restricted that a wheelchair becomes a necessity.
Formal identification of nephrogenic systemic fibrosis occurred in 2000. The FDA has monitored its development and in 2007 has taken several actions, raising warning flags about the relationship between NSF and gadolinium MRI exams. In May the Agency asked the manufacturers to include a warning. In July, they put out a public health advisory about the relationship between the onset of nephrogenic systemic fibrosis and gadolinium MRI studies.
Some people who have nephrogenic systemic fibrosis have sought legal help because of their unknowing exposure to a dangerous medical substance. If you or someone around you has had an MRI and has developed side effects or NSF symptoms, you can get a thorough analysis of your legal case from our office. Just call or email us and one of our professionals will go over the issue with you in detail and without charge.
Nephrogenic Systemic Fibrosis In The News
Methods For Conducting Magnetic Resonance Angiography Safely In Patients With Contraindications To GadoliniumNephrogenic systemic fibrosis (NSF) was first recognized in 1997 and described in 2000, and its association with gadolinium contrast agents was recognized in 2006. NSF is characterized by increased deposits of collagen, most frequently in the skin, but it can be systemic, and in severe cases fatal. There is no known consistently effective therapy. In 2006 and 2007 the U.S.
